TGFB1 and cholangiocarcinoma: TGFβ-treated RBE human CCA cells exhibited elevated apoptosis, a process that was SMAD-dependent and augmented by inhibition of the c-Jun N-terminal kinase (JNK), using the chemical inhibitor SP600125 [84].